Pfizer’s Paxlovid Ineffective as 15-Day Treatment for Long COVID, Stanford Study Finds
A Stanford University study has found that a 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid does not alleviate symptoms...
Read moreA Stanford University study has found that a 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid does not alleviate symptoms...
Read moreThe Food and Drug Administration has approved GSK's respiratory syncytial virus (RSV) vaccine for at-risk adults starting from age 50,...
Read morePrime Bank PLC has recently inaugurated a new Agent Banking Outlet at Sorno Komol Market, Rajbari Raster More, Faridpur Sadar....
Read moreIn a move to enhance insurance accessibility, United Commercial Bank Plc (UCB) has entered into a strategic partnership with Jiban...
Read moreFor the first time in the country's Mobile Financial Services (MFS), bKash introduces a 'Student Account' aimed at preparing teenagers...
Read more© 2023 Info Craze - Developer by REPWOOP.
© 2023 Info Craze - Developer by REPWOOP.